Article Versions Notes

Papadimitriou K, Tsakirakis N, Malandrakis P, Vitsos P, Metousis A, Orologas-Stavrou N, Ntanasis-Stathopoulos I, Kanellias N, Eleutherakis-Papaiakovou E, Pothos P, et al. Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma. Cancers. 2020; 12(11):3245. https://doi.org/10.3390/cancers12113245

Papadimitriou, Konstantinos, Nikolaos Tsakirakis, Panagiotis Malandrakis, Panagiotis Vitsos, Andreas Metousis, Nikolaos Orologas-Stavrou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Pothos, and et al. 2020. "Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma" Cancers 12, no. 11: 3245. https://doi.org/10.3390/cancers12113245

Papadimitriou, K., Tsakirakis, N., Malandrakis, P., Vitsos, P., Metousis, A., Orologas-Stavrou, N., Ntanasis-Stathopoulos, I., Kanellias, N., Eleutherakis-Papaiakovou, E., Pothos, P., Fotiou, D., Gavriatopoulou, M., Kastritis, E., Dimopoulos, M. -A., Terpos, E., Tsitsilonis, O. E., & Kostopoulos, I. V. (2020). Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma. Cancers, 12(11), 3245. https://doi.org/10.3390/cancers12113245